BioMaxima Market Cap

BioMaxima has a market cap or net worth of 49.23 million as of April 29, 2026. Its market cap has decreased by -8.99% in one year.

Market Cap

49.23M

Enterprise Value

64.08M

Revenue

59.11M

Ranking

n/a

PE Ratio

78.27

Stock Price

11.76

Market Cap Chart

Since July 21, 2010, BioMaxima's market cap has increased from 11.40M to 49.23M, an increase of 331.68%. That is a compound annual growth rate of 9.71%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	49.23M	-2.57%
Dec 30, 2025	50.53M	12.62%
Dec 30, 2024	44.87M	-34.84%
Dec 29, 2023	68.85M	-35.28%
Dec 30, 2022	106.38M	-6.37%
Dec 30, 2021	113.62M	-4.71%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 27, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Diagnostyka	5.11B
NEUCA	3.21B
Synektik Spólka Akcyjna	2.42B
Celon Pharma	1.16B
Genomtec	70.80M
Urteste	61.32M
Read-Gene	60.84M
Sygnis	48.62M

Market Cap Rankings